Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OncoTherad for BCG-recurrent or BCG-relapsed non-muscle invasive bladder cancer
RBR-6swqd2Phase 2Recruiting
- Sponsor
- Universidade Estadual de Campinas
- Start
- Aug 2018
- Modality
- Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of OncoTherad in non-muscle-invasive bladder cancer (NMIBC) and bladder cancer, sponsored by Universidade Estadual de Campinas. Started Aug 2018; status: recruiting.
02
Drugs
OncoTherad
03
Conditions
non-muscle-invasive bladder cancer (NMIBC)bladder cancer
Beyond the preview
Go deeper on RBR-6swqd2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-6swqd2.